Bartlett, Maggie L.
Miley, Kristi
Vermund, Sten H.
Weaver, Scott C.
Article History
Received: 16 June 2025
Accepted: 18 September 2025
First Online: 10 October 2025
Declarations
:
: All authors have reviewed and approved the final manuscript and consent to its publication.
: Not applicable.
: M.L.B. is employed by Johns Hopkins University, holds an Ehlers Danlos research grant, advises Persistence Bio and Alveo, and is co-founder of CureX Technology and Infectious Insight. S.H.V. is employed by the University of South Florida, receives research funding from the NIH and USAID, and serves on scientific advisory boards for Moderna, Tevogen Bio, Porosome Theraputics, and Immugen BioPharma. S.C.W. is a consultant for Valneva.